Intracranial Pressure (ICP) Monitoring Market By Technique (Invasive, Non-Invasive), By Application (Traumatic Brain Injury, Intracerebral Hemorrhage, Meningitis, Others) By End User (Hospital, Clinics, Private Medical Offices, Trauma Centers, Government and Research Organizations) : Global Opportunity Analysis and Industry Forecast, 2024-2033
Intracranial Pressure (ICP) Monitoring Market
The intracranial pressure (ICP) monitoring market was valued at $0.4 billion in 2023, and is projected to reach $0.6 billion by 2033, growing at a CAGR of 5.1% from 2024 to 2033.
ICP monitoring is a diagnostic test for measuring the pressure inside the skull, exerted by certain fluids such as cerebrospinal fluid and blood within the cranial cavity. A catheter or sensor is inserted into the cerebrospinal fluid space of brain in this procedure to gauge the pressure. Conducting ICP monitoring is pivotal in various medical conditions, including stroke, traumatic brain injury, brain tumors, and neurological disorders. Healthcare providers assess the intensity of brain injury through ICP monitoring, identify modifications in intracranial dynamics, and make treatment decisions.
Surge in the efficacy of ICP monitoring due to continuous technological advancements is a major driver of the market. Wireless connectivity, miniaturization of sensors, and assimilation with digital health platforms have enabled healthcare providers to garner real-time data, make well-informed decisions, and elevate patient care in neurocritical settings. In future, the trend of non-invasive ICP monitoring is projected to dominate in the healthcare settings. Currently, R&D efforts are in full pace to mitigate the limitations of existing non-invasive procedures such as transcranial doppler ultrasonography, brain tissue resonance, and venous ophthalmodynamometry.
However, cutting-edge technological advancements result in high cost of diagnostic tests, making it unaffordable for several individuals. Moreover, the high initial cost of procuring equipment associated with ICP monitoring; along with calibration, maintenance, and consumable expenses; makes it challenging for several small & medium-sized healthcare facilities to invest in them. On the contrary, the deployment of AI is a field of innovation expected to open new avenues for the intracranial pressure (ICP) monitoring market. AI is anticipated to analyze large datasets generated from the equipment and identify the abnormalities that are possible skippable by human observation. Suggestions offered by predictive model of AI are projected to aid in on-time delivery of medical responses, hence improving patient outcomes.
Segment Review
The intracranial pressure (ICP) monitoring market is segmented into technique, application, end user, and region. On the basis of technique, the market is bifurcated into invasive and non-invasive. By application, it is divided into traumatic brain injury, intracerebral hemorrhage, meningitis, and others. Depending on end user, it is classified into hospital, clinics, private medical offices, trauma centers, and government & research organizations. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
On the basis of technique, the non-invasive segment generated the highest revenue in the market in 2023.
By application, the traumatic brain injury segment was the highest revenue generator in 2023
Depending on end user, the hospital segment acquired higher stakes of the market in 2023.
Competition Analysis
The major players operating in the global intracranial pressure (ICP) monitoring market include BrainLAB, Natus Medical Incorporated, Integra LifeSciences, GE Healthcare, Teleflex Incorporated, Sick AG, Smiths Medical, Koninklijke Philips N.V, Elekta AB, and AMETEK. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.
Key Market Segments
By Technique
Invasive
Non-Invasive
By Application
Traumatic Brain Injury
Intracerebral Hemorrhage
Meningitis
Others
By End User
Hospital
Clinics
Private Medical Offices
Trauma Centers
Government and Research Organizations
By Region
North America
U.S.
Canada
Mexico
Europe
France
Germany
Italy
Spain
UK
Rest of Europe
Asia-Pacific
China
Japan
India
South Korea
Australia
Rest of Asia-Pacific
LAMEA
Brazil
South Africa
Saudi Arabia
Rest of LAMEA
Key Market Players
BrainLAB
Natus Medical Incorporated
Integra LifeSciences
GE Healthcare
Teleflex Incorporated
Sick AG
Smiths Medical
Koninklijke Philips N.V
Elekta AB
AMETEK
- CHAPTER 1: INTRODUCTION
- 1.1. Report Description
- 1.2. Key Market Segments
- 1.3. Key Benefits
- 1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models
- CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
- CHAPTER 3: MARKET LANDSCAPE
- 3.1. Market Definition and Scope
- 3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
- 3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
- 3.5. Market Dynamics
- 3.5.1. Drivers
- 3.5.2. Restraints
- 3.5.3. Opportunities
- CHAPTER 4: INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TECHNIQUE
- 4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Technique
- 4.2. Invasive
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
- 4.3. Non-Invasive
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country
- CHAPTER 5: INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY APPLICATION
- 5.1. Market Overview
- 5.1.1 Market Size and Forecast, By Application
- 5.2. Traumatic Brain Injury
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
- 5.3. Intracerebral Hemorrhage
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country
- 5.4. Meningitis
- 5.4.1. Key Market Trends, Growth Factors and Opportunities
- 5.4.2. Market Size and Forecast, By Region
- 5.4.3. Market Share Analysis, By Country
- 5.5. Others
- 5.5.1. Key Market Trends, Growth Factors and Opportunities
- 5.5.2. Market Size and Forecast, By Region
- 5.5.3. Market Share Analysis, By Country
- CHAPTER 6: INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY END USER
- 6.1. Market Overview
- 6.1.1 Market Size and Forecast, By End User
- 6.2. Hospital
- 6.2.1. Key Market Trends, Growth Factors and Opportunities
- 6.2.2. Market Size and Forecast, By Region
- 6.2.3. Market Share Analysis, By Country
- 6.3. Clinics
- 6.3.1. Key Market Trends, Growth Factors and Opportunities
- 6.3.2. Market Size and Forecast, By Region
- 6.3.3. Market Share Analysis, By Country
- 6.4. Private Medical Offices
- 6.4.1. Key Market Trends, Growth Factors and Opportunities
- 6.4.2. Market Size and Forecast, By Region
- 6.4.3. Market Share Analysis, By Country
- 6.5. Trauma Centers
- 6.5.1. Key Market Trends, Growth Factors and Opportunities
- 6.5.2. Market Size and Forecast, By Region
- 6.5.3. Market Share Analysis, By Country
- 6.6. Government And Research Organizations
- 6.6.1. Key Market Trends, Growth Factors and Opportunities
- 6.6.2. Market Size and Forecast, By Region
- 6.6.3. Market Share Analysis, By Country
- CHAPTER 7: INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY REGION
- 7.1. Market Overview
- 7.1.1 Market Size and Forecast, By Region
- 7.2. North America
- 7.2.1. Key Market Trends and Opportunities
- 7.2.2. Market Size and Forecast, By Technique
- 7.2.3. Market Size and Forecast, By Application
- 7.2.4. Market Size and Forecast, By End User
- 7.2.5. Market Size and Forecast, By Country
- 7.2.6. U.S. Intracranial Pressure (ICP) Monitoring Market
- 7.2.6.1. Market Size and Forecast, By Technique
- 7.2.6.2. Market Size and Forecast, By Application
- 7.2.6.3. Market Size and Forecast, By End User
- 7.2.7. Canada Intracranial Pressure (ICP) Monitoring Market
- 7.2.7.1. Market Size and Forecast, By Technique
- 7.2.7.2. Market Size and Forecast, By Application
- 7.2.7.3. Market Size and Forecast, By End User
- 7.2.8. Mexico Intracranial Pressure (ICP) Monitoring Market
- 7.2.8.1. Market Size and Forecast, By Technique
- 7.2.8.2. Market Size and Forecast, By Application
- 7.2.8.3. Market Size and Forecast, By End User
- 7.3. Europe
- 7.3.1. Key Market Trends and Opportunities
- 7.3.2. Market Size and Forecast, By Technique
- 7.3.3. Market Size and Forecast, By Application
- 7.3.4. Market Size and Forecast, By End User
- 7.3.5. Market Size and Forecast, By Country
- 7.3.6. France Intracranial Pressure (ICP) Monitoring Market
- 7.3.6.1. Market Size and Forecast, By Technique
- 7.3.6.2. Market Size and Forecast, By Application
- 7.3.6.3. Market Size and Forecast, By End User
- 7.3.7. Germany Intracranial Pressure (ICP) Monitoring Market
- 7.3.7.1. Market Size and Forecast, By Technique
- 7.3.7.2. Market Size and Forecast, By Application
- 7.3.7.3. Market Size and Forecast, By End User
- 7.3.8. Italy Intracranial Pressure (ICP) Monitoring Market
- 7.3.8.1. Market Size and Forecast, By Technique
- 7.3.8.2. Market Size and Forecast, By Application
- 7.3.8.3. Market Size and Forecast, By End User
- 7.3.9. Spain Intracranial Pressure (ICP) Monitoring Market
- 7.3.9.1. Market Size and Forecast, By Technique
- 7.3.9.2. Market Size and Forecast, By Application
- 7.3.9.3. Market Size and Forecast, By End User
- 7.3.10. UK Intracranial Pressure (ICP) Monitoring Market
- 7.3.10.1. Market Size and Forecast, By Technique
- 7.3.10.2. Market Size and Forecast, By Application
- 7.3.10.3. Market Size and Forecast, By End User
- 7.3.11. Rest Of Europe Intracranial Pressure (ICP) Monitoring Market
- 7.3.11.1. Market Size and Forecast, By Technique
- 7.3.11.2. Market Size and Forecast, By Application
- 7.3.11.3. Market Size and Forecast, By End User
- 7.4. Asia-Pacific
- 7.4.1. Key Market Trends and Opportunities
- 7.4.2. Market Size and Forecast, By Technique
- 7.4.3. Market Size and Forecast, By Application
- 7.4.4. Market Size and Forecast, By End User
- 7.4.5. Market Size and Forecast, By Country
- 7.4.6. China Intracranial Pressure (ICP) Monitoring Market
- 7.4.6.1. Market Size and Forecast, By Technique
- 7.4.6.2. Market Size and Forecast, By Application
- 7.4.6.3. Market Size and Forecast, By End User
- 7.4.7. Japan Intracranial Pressure (ICP) Monitoring Market
- 7.4.7.1. Market Size and Forecast, By Technique
- 7.4.7.2. Market Size and Forecast, By Application
- 7.4.7.3. Market Size and Forecast, By End User
- 7.4.8. India Intracranial Pressure (ICP) Monitoring Market
- 7.4.8.1. Market Size and Forecast, By Technique
- 7.4.8.2. Market Size and Forecast, By Application
- 7.4.8.3. Market Size and Forecast, By End User
- 7.4.9. South Korea Intracranial Pressure (ICP) Monitoring Market
- 7.4.9.1. Market Size and Forecast, By Technique
- 7.4.9.2. Market Size and Forecast, By Application
- 7.4.9.3. Market Size and Forecast, By End User
- 7.4.10. Australia Intracranial Pressure (ICP) Monitoring Market
- 7.4.10.1. Market Size and Forecast, By Technique
- 7.4.10.2. Market Size and Forecast, By Application
- 7.4.10.3. Market Size and Forecast, By End User
- 7.4.11. Rest of Asia-Pacific Intracranial Pressure (ICP) Monitoring Market
- 7.4.11.1. Market Size and Forecast, By Technique
- 7.4.11.2. Market Size and Forecast, By Application
- 7.4.11.3. Market Size and Forecast, By End User
- 7.5. LAMEA
- 7.5.1. Key Market Trends and Opportunities
- 7.5.2. Market Size and Forecast, By Technique
- 7.5.3. Market Size and Forecast, By Application
- 7.5.4. Market Size and Forecast, By End User
- 7.5.5. Market Size and Forecast, By Country
- 7.5.6. Brazil Intracranial Pressure (ICP) Monitoring Market
- 7.5.6.1. Market Size and Forecast, By Technique
- 7.5.6.2. Market Size and Forecast, By Application
- 7.5.6.3. Market Size and Forecast, By End User
- 7.5.7. South Africa Intracranial Pressure (ICP) Monitoring Market
- 7.5.7.1. Market Size and Forecast, By Technique
- 7.5.7.2. Market Size and Forecast, By Application
- 7.5.7.3. Market Size and Forecast, By End User
- 7.5.8. Saudi Arabia Intracranial Pressure (ICP) Monitoring Market
- 7.5.8.1. Market Size and Forecast, By Technique
- 7.5.8.2. Market Size and Forecast, By Application
- 7.5.8.3. Market Size and Forecast, By End User
- 7.5.9. Rest of LAMEA Intracranial Pressure (ICP) Monitoring Market
- 7.5.9.1. Market Size and Forecast, By Technique
- 7.5.9.2. Market Size and Forecast, By Application
- 7.5.9.3. Market Size and Forecast, By End User
- CHAPTER 8: COMPETITIVE LANDSCAPE
- 8.1. Introduction
- 8.2. Top Winning Strategies
- 8.3. Product Mapping Of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Top Player Positioning, 2023
- CHAPTER 9: COMPANY PROFILES
- 9.1. BrainLAB
- 9.1.1. Company Overview
- 9.1.2. Key Executives
- 9.1.3. Company Snapshot
- 9.1.4. Operating Business Segments
- 9.1.5. Product Portfolio
- 9.1.6. Business Performance
- 9.1.7. Key Strategic Moves and Developments
- 9.2. Natus Medical Incorporated
- 9.2.1. Company Overview
- 9.2.2. Key Executives
- 9.2.3. Company Snapshot
- 9.2.4. Operating Business Segments
- 9.2.5. Product Portfolio
- 9.2.6. Business Performance
- 9.2.7. Key Strategic Moves and Developments
- 9.3. Integra LifeSciences
- 9.3.1. Company Overview
- 9.3.2. Key Executives
- 9.3.3. Company Snapshot
- 9.3.4. Operating Business Segments
- 9.3.5. Product Portfolio
- 9.3.6. Business Performance
- 9.3.7. Key Strategic Moves and Developments
- 9.4. GE Healthcare
- 9.4.1. Company Overview
- 9.4.2. Key Executives
- 9.4.3. Company Snapshot
- 9.4.4. Operating Business Segments
- 9.4.5. Product Portfolio
- 9.4.6. Business Performance
- 9.4.7. Key Strategic Moves and Developments
- 9.5. Teleflex Incorporated
- 9.5.1. Company Overview
- 9.5.2. Key Executives
- 9.5.3. Company Snapshot
- 9.5.4. Operating Business Segments
- 9.5.5. Product Portfolio
- 9.5.6. Business Performance
- 9.5.7. Key Strategic Moves and Developments
- 9.6. Sick AG
- 9.6.1. Company Overview
- 9.6.2. Key Executives
- 9.6.3. Company Snapshot
- 9.6.4. Operating Business Segments
- 9.6.5. Product Portfolio
- 9.6.6. Business Performance
- 9.6.7. Key Strategic Moves and Developments
- 9.7. Smiths Medical
- 9.7.1. Company Overview
- 9.7.2. Key Executives
- 9.7.3. Company Snapshot
- 9.7.4. Operating Business Segments
- 9.7.5. Product Portfolio
- 9.7.6. Business Performance
- 9.7.7. Key Strategic Moves and Developments
- 9.8. Koninklijke Philips N.V
- 9.8.1. Company Overview
- 9.8.2. Key Executives
- 9.8.3. Company Snapshot
- 9.8.4. Operating Business Segments
- 9.8.5. Product Portfolio
- 9.8.6. Business Performance
- 9.8.7. Key Strategic Moves and Developments
- 9.9. Elekta AB
- 9.9.1. Company Overview
- 9.9.2. Key Executives
- 9.9.3. Company Snapshot
- 9.9.4. Operating Business Segments
- 9.9.5. Product Portfolio
- 9.9.6. Business Performance
- 9.9.7. Key Strategic Moves and Developments
- 9.10. AMETEK
- 9.10.1. Company Overview
- 9.10.2. Key Executives
- 9.10.3. Company Snapshot
- 9.10.4. Operating Business Segments
- 9.10.5. Product Portfolio
- 9.10.6. Business Performance
- 9.10.7. Key Strategic Moves and Developments
- TABLE 1. GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TECHNIQUE, 2024 - 2033 ($BILLION)
- TABLE 2. INTRACRANIAL PRESSURE (ICP) MONITORING MARKET FOR INVASIVE, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 3. INTRACRANIAL PRESSURE (ICP) MONITORING MARKET FOR NON-INVASIVE, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 4. GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 5. INTRACRANIAL PRESSURE (ICP) MONITORING MARKET FOR TRAUMATIC BRAIN INJURY, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 6. INTRACRANIAL PRESSURE (ICP) MONITORING MARKET FOR INTRACEREBRAL HEMORRHAGE, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 7. INTRACRANIAL PRESSURE (ICP) MONITORING MARKET FOR MENINGITIS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 8. INTRACRANIAL PRESSURE (ICP) MONITORING MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 9. GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 10. INTRACRANIAL PRESSURE (ICP) MONITORING MARKET FOR HOSPITAL, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 11. INTRACRANIAL PRESSURE (ICP) MONITORING MARKET FOR CLINICS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 12. INTRACRANIAL PRESSURE (ICP) MONITORING MARKET FOR PRIVATE MEDICAL OFFICES, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 13. INTRACRANIAL PRESSURE (ICP) MONITORING MARKET FOR TRAUMA CENTERS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 14. INTRACRANIAL PRESSURE (ICP) MONITORING MARKET FOR GOVERNMENT AND RESEARCH ORGANIZATIONS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 15. INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 16. NORTH AMERICA INTRACRANIAL PRESSURE (ICP) MONITORING, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 17. NORTH AMERICA INTRACRANIAL PRESSURE (ICP) MONITORING, BY TECHNIQUE, 2024 - 2033 ($BILLION)
- TABLE 18. NORTH AMERICA INTRACRANIAL PRESSURE (ICP) MONITORING, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 19. NORTH AMERICA INTRACRANIAL PRESSURE (ICP) MONITORING, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 20. U.S. INTRACRANIAL PRESSURE (ICP) MONITORING, BY TECHNIQUE, 2024 - 2033 ($BILLION)
- TABLE 21. U.S. INTRACRANIAL PRESSURE (ICP) MONITORING, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 22. U.S. INTRACRANIAL PRESSURE (ICP) MONITORING, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 23. CANADA INTRACRANIAL PRESSURE (ICP) MONITORING, BY TECHNIQUE, 2024 - 2033 ($BILLION)
- TABLE 24. CANADA INTRACRANIAL PRESSURE (ICP) MONITORING, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 25. CANADA INTRACRANIAL PRESSURE (ICP) MONITORING, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 26. MEXICO INTRACRANIAL PRESSURE (ICP) MONITORING, BY TECHNIQUE, 2024 - 2033 ($BILLION)
- TABLE 27. MEXICO INTRACRANIAL PRESSURE (ICP) MONITORING, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 28. MEXICO INTRACRANIAL PRESSURE (ICP) MONITORING, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 29. EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 30. EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING, BY TECHNIQUE, 2024 - 2033 ($BILLION)
- TABLE 31. EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 32. EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 33. FRANCE INTRACRANIAL PRESSURE (ICP) MONITORING, BY TECHNIQUE, 2024 - 2033 ($BILLION)
- TABLE 34. FRANCE INTRACRANIAL PRESSURE (ICP) MONITORING, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 35. FRANCE INTRACRANIAL PRESSURE (ICP) MONITORING, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 36. GERMANY INTRACRANIAL PRESSURE (ICP) MONITORING, BY TECHNIQUE, 2024 - 2033 ($BILLION)
- TABLE 37. GERMANY INTRACRANIAL PRESSURE (ICP) MONITORING, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 38. GERMANY INTRACRANIAL PRESSURE (ICP) MONITORING, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 39. ITALY INTRACRANIAL PRESSURE (ICP) MONITORING, BY TECHNIQUE, 2024 - 2033 ($BILLION)
- TABLE 40. ITALY INTRACRANIAL PRESSURE (ICP) MONITORING, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 41. ITALY INTRACRANIAL PRESSURE (ICP) MONITORING, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 42. SPAIN INTRACRANIAL PRESSURE (ICP) MONITORING, BY TECHNIQUE, 2024 - 2033 ($BILLION)
- TABLE 43. SPAIN INTRACRANIAL PRESSURE (ICP) MONITORING, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 44. SPAIN INTRACRANIAL PRESSURE (ICP) MONITORING, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 45. UK INTRACRANIAL PRESSURE (ICP) MONITORING, BY TECHNIQUE, 2024 - 2033 ($BILLION)
- TABLE 46. UK INTRACRANIAL PRESSURE (ICP) MONITORING, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 47. UK INTRACRANIAL PRESSURE (ICP) MONITORING, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 48. REST OF EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING, BY TECHNIQUE, 2024 - 2033 ($BILLION)
- TABLE 49. REST OF EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 50. REST OF EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 51. ASIA-PACIFIC INTRACRANIAL PRESSURE (ICP) MONITORING, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 52. ASIA-PACIFIC INTRACRANIAL PRESSURE (ICP) MONITORING, BY TECHNIQUE, 2024 - 2033 ($BILLION)
- TABLE 53. ASIA-PACIFIC INTRACRANIAL PRESSURE (ICP) MONITORING, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 54. ASIA-PACIFIC INTRACRANIAL PRESSURE (ICP) MONITORING, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 55. CHINA INTRACRANIAL PRESSURE (ICP) MONITORING, BY TECHNIQUE, 2024 - 2033 ($BILLION)
- TABLE 56. CHINA INTRACRANIAL PRESSURE (ICP) MONITORING, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 57. CHINA INTRACRANIAL PRESSURE (ICP) MONITORING, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 58. JAPAN INTRACRANIAL PRESSURE (ICP) MONITORING, BY TECHNIQUE, 2024 - 2033 ($BILLION)
- TABLE 59. JAPAN INTRACRANIAL PRESSURE (ICP) MONITORING, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 60. JAPAN INTRACRANIAL PRESSURE (ICP) MONITORING, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 61. INDIA INTRACRANIAL PRESSURE (ICP) MONITORING, BY TECHNIQUE, 2024 - 2033 ($BILLION)
- TABLE 62. INDIA INTRACRANIAL PRESSURE (ICP) MONITORING, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 63. INDIA INTRACRANIAL PRESSURE (ICP) MONITORING, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 64. SOUTH KOREA INTRACRANIAL PRESSURE (ICP) MONITORING, BY TECHNIQUE, 2024 - 2033 ($BILLION)
- TABLE 65. SOUTH KOREA INTRACRANIAL PRESSURE (ICP) MONITORING, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 66. SOUTH KOREA INTRACRANIAL PRESSURE (ICP) MONITORING, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 67. AUSTRALIA INTRACRANIAL PRESSURE (ICP) MONITORING, BY TECHNIQUE, 2024 - 2033 ($BILLION)
- TABLE 68. AUSTRALIA INTRACRANIAL PRESSURE (ICP) MONITORING, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 69. AUSTRALIA INTRACRANIAL PRESSURE (ICP) MONITORING, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 70. REST OF ASIA-PACIFIC INTRACRANIAL PRESSURE (ICP) MONITORING, BY TECHNIQUE, 2024 - 2033 ($BILLION)
- TABLE 71. REST OF ASIA-PACIFIC INTRACRANIAL PRESSURE (ICP) MONITORING, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 72. REST OF ASIA-PACIFIC INTRACRANIAL PRESSURE (ICP) MONITORING, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 73. LAMEA INTRACRANIAL PRESSURE (ICP) MONITORING, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 74. LAMEA INTRACRANIAL PRESSURE (ICP) MONITORING, BY TECHNIQUE, 2024 - 2033 ($BILLION)
- TABLE 75. LAMEA INTRACRANIAL PRESSURE (ICP) MONITORING, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 76. LAMEA INTRACRANIAL PRESSURE (ICP) MONITORING, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 77. BRAZIL INTRACRANIAL PRESSURE (ICP) MONITORING, BY TECHNIQUE, 2024 - 2033 ($BILLION)
- TABLE 78. BRAZIL INTRACRANIAL PRESSURE (ICP) MONITORING, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 79. BRAZIL INTRACRANIAL PRESSURE (ICP) MONITORING, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 80. SOUTH AFRICA INTRACRANIAL PRESSURE (ICP) MONITORING, BY TECHNIQUE, 2024 - 2033 ($BILLION)
- TABLE 81. SOUTH AFRICA INTRACRANIAL PRESSURE (ICP) MONITORING, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 82. SOUTH AFRICA INTRACRANIAL PRESSURE (ICP) MONITORING, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 83. SAUDI ARABIA INTRACRANIAL PRESSURE (ICP) MONITORING, BY TECHNIQUE, 2024 - 2033 ($BILLION)
- TABLE 84. SAUDI ARABIA INTRACRANIAL PRESSURE (ICP) MONITORING, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 85. SAUDI ARABIA INTRACRANIAL PRESSURE (ICP) MONITORING, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 86. REST OF LAMEA INTRACRANIAL PRESSURE (ICP) MONITORING, BY TECHNIQUE, 2024 - 2033 ($BILLION)
- TABLE 87. REST OF LAMEA INTRACRANIAL PRESSURE (ICP) MONITORING, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 88. REST OF LAMEA INTRACRANIAL PRESSURE (ICP) MONITORING, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 89. BRAINLAB: KEY EXECUTIVES
- TABLE 90. BRAINLAB: COMPANY SNAPSHOT
- TABLE 91. BRAINLAB: OPERATING SEGMENTS
- TABLE 92. BRAINLAB: PRODUCT PORTFOLIO
- TABLE 93. BRAINLAB: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 94. NATUS MEDICAL INCORPORATED: KEY EXECUTIVES
- TABLE 95. NATUS MEDICAL INCORPORATED: COMPANY SNAPSHOT
- TABLE 96. NATUS MEDICAL INCORPORATED: OPERATING SEGMENTS
- TABLE 97. NATUS MEDICAL INCORPORATED: PRODUCT PORTFOLIO
- TABLE 98. NATUS MEDICAL INCORPORATED: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 99. INTEGRA LIFESCIENCES: KEY EXECUTIVES
- TABLE 100. INTEGRA LIFESCIENCES: COMPANY SNAPSHOT
- TABLE 101. INTEGRA LIFESCIENCES: OPERATING SEGMENTS
- TABLE 102. INTEGRA LIFESCIENCES: PRODUCT PORTFOLIO
- TABLE 103. INTEGRA LIFESCIENCES: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 104. GE HEALTHCARE: KEY EXECUTIVES
- TABLE 105. GE HEALTHCARE: COMPANY SNAPSHOT
- TABLE 106. GE HEALTHCARE: OPERATING SEGMENTS
- TABLE 107. GE HEALTHCARE: PRODUCT PORTFOLIO
- TABLE 108. GE HEALTHCARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 109. TELEFLEX INCORPORATED: KEY EXECUTIVES
- TABLE 110. TELEFLEX INCORPORATED: COMPANY SNAPSHOT
- TABLE 111. TELEFLEX INCORPORATED: OPERATING SEGMENTS
- TABLE 112. TELEFLEX INCORPORATED: PRODUCT PORTFOLIO
- TABLE 113. TELEFLEX INCORPORATED: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 114. SICK AG: KEY EXECUTIVES
- TABLE 115. SICK AG: COMPANY SNAPSHOT
- TABLE 116. SICK AG: OPERATING SEGMENTS
- TABLE 117. SICK AG: PRODUCT PORTFOLIO
- TABLE 118. SICK AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 119. SMITHS MEDICAL: KEY EXECUTIVES
- TABLE 120. SMITHS MEDICAL: COMPANY SNAPSHOT
- TABLE 121. SMITHS MEDICAL: OPERATING SEGMENTS
- TABLE 122. SMITHS MEDICAL: PRODUCT PORTFOLIO
- TABLE 123. SMITHS MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 124. KONINKLIJKE PHILIPS N.V: KEY EXECUTIVES
- TABLE 125. KONINKLIJKE PHILIPS N.V: COMPANY SNAPSHOT
- TABLE 126. KONINKLIJKE PHILIPS N.V: OPERATING SEGMENTS
- TABLE 127. KONINKLIJKE PHILIPS N.V: PRODUCT PORTFOLIO
- TABLE 128. KONINKLIJKE PHILIPS N.V: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 129. ELEKTA AB: KEY EXECUTIVES
- TABLE 130. ELEKTA AB: COMPANY SNAPSHOT
- TABLE 131. ELEKTA AB: OPERATING SEGMENTS
- TABLE 132. ELEKTA AB: PRODUCT PORTFOLIO
- TABLE 133. ELEKTA AB: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 134. AMETEK: KEY EXECUTIVES
- TABLE 135. AMETEK: COMPANY SNAPSHOT
- TABLE 136. AMETEK: OPERATING SEGMENTS
- TABLE 137. AMETEK: PRODUCT PORTFOLIO
- TABLE 138. AMETEK: KEY STRATEGIC MOVES AND DEVELOPMENTS
- FIGURE 1. GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET SEGMENTATION
- FIGURE 2. GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET
- FIGURE 3. SEGMENTATION INTRACRANIAL PRESSURE (ICP) MONITORING MARKET
- FIGURE 4. TOP INVESTMENT POCKET IN INTRACRANIAL PRESSURE (ICP) MONITORING MARKET
- FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
- FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
- FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
- FIGURE 8. LOW THREAT OF SUBSTITUTION
- FIGURE 9. HIGH COMPETITIVE RIVALRY
- FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALINTRACRANIAL PRESSURE (ICP) MONITORING MARKET
- FIGURE 11. GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET SEGMENTATION, BY TECHNIQUE
- FIGURE 12. INTRACRANIAL PRESSURE (ICP) MONITORING MARKET FOR INVASIVE, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 13. INTRACRANIAL PRESSURE (ICP) MONITORING MARKET FOR NON-INVASIVE, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 14. GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET SEGMENTATION, BY APPLICATION
- FIGURE 15. INTRACRANIAL PRESSURE (ICP) MONITORING MARKET FOR TRAUMATIC BRAIN INJURY, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 16. INTRACRANIAL PRESSURE (ICP) MONITORING MARKET FOR INTRACEREBRAL HEMORRHAGE, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 17. INTRACRANIAL PRESSURE (ICP) MONITORING MARKET FOR MENINGITIS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 18. INTRACRANIAL PRESSURE (ICP) MONITORING MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 19. GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET SEGMENTATION, BY END USER
- FIGURE 20. INTRACRANIAL PRESSURE (ICP) MONITORING MARKET FOR HOSPITAL, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 21. INTRACRANIAL PRESSURE (ICP) MONITORING MARKET FOR CLINICS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 22. INTRACRANIAL PRESSURE (ICP) MONITORING MARKET FOR PRIVATE MEDICAL OFFICES, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 23. INTRACRANIAL PRESSURE (ICP) MONITORING MARKET FOR TRAUMA CENTERS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 24. INTRACRANIAL PRESSURE (ICP) MONITORING MARKET FOR GOVERNMENT AND RESEARCH ORGANIZATIONS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 25. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
- FIGURE 26. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
- FIGURE 27. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
- FIGURE 28. PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 29. COMPETITIVE DASHBOARD
- FIGURE 30. COMPETITIVE HEATMAP: INTRACRANIAL PRESSURE (ICP) MONITORING MARKET
- FIGURE 31. TOP PLAYER POSITIONING, 2023
- FIGURE 32. BRAINLAB: NET SALES, 2021-2023 ($BILLION)
- FIGURE 33. BRAINLAB: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 34. BRAINLAB: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 35. NATUS MEDICAL INCORPORATED: NET SALES, 2021-2023 ($BILLION)
- FIGURE 36. NATUS MEDICAL INCORPORATED: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 37. NATUS MEDICAL INCORPORATED: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 38. INTEGRA LIFESCIENCES: NET SALES, 2021-2023 ($BILLION)
- FIGURE 39. INTEGRA LIFESCIENCES: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 40. INTEGRA LIFESCIENCES: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 41. GE HEALTHCARE: NET SALES, 2021-2023 ($BILLION)
- FIGURE 42. GE HEALTHCARE: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 43. GE HEALTHCARE: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 44. TELEFLEX INCORPORATED: NET SALES, 2021-2023 ($BILLION)
- FIGURE 45. TELEFLEX INCORPORATED: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 46. TELEFLEX INCORPORATED: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 47. SICK AG: NET SALES, 2021-2023 ($BILLION)
- FIGURE 48. SICK AG: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 49. SICK AG: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 50. SMITHS MEDICAL: NET SALES, 2021-2023 ($BILLION)
- FIGURE 51. SMITHS MEDICAL: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 52. SMITHS MEDICAL: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 53. KONINKLIJKE PHILIPS N.V: NET SALES, 2021-2023 ($BILLION)
- FIGURE 54. KONINKLIJKE PHILIPS N.V: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 55. KONINKLIJKE PHILIPS N.V: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 56. ELEKTA AB: NET SALES, 2021-2023 ($BILLION)
- FIGURE 57. ELEKTA AB: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 58. ELEKTA AB: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 59. AMETEK: NET SALES, 2021-2023 ($BILLION)
- FIGURE 60. AMETEK: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 61. AMETEK: REVENUE SHARE, BY REGION, 2023 (%)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook